Skip to content

Research on the correlation between gestational blood glucose fluctuations and maternal and neonatal outcomes

Research on the correlation between gestational blood glucose fluctuations and maternal and neonatal outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107634
Enrollment
Unknown
Registered
2025-08-15
Start date
2025-08-15
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes in Pregnancy

Interventions

Maternal population observation group:None

Sponsors

Beijing Pinggu Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 36 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-36 years. 2.Single pregnancy. 3.No other serious complications. 4.Voluntarily participate in this study and sign an informed consent form. 5.Undergo prenatal examination in our hospital.

Exclusion criteria

Exclusion criteria: 1.Pregnant women with a clear diagnosis of diabetes mellitus at the time of screening. 2.Suffering from severe cardiac, hepatic, renal and other vital organ dysfunction. 3.Having serious mental illnesses, such as depression, anxiety, etc. 4.Combined with other serious infectious diseases, such as AIDS, syphilis, etc. 5.Refuse to wear CGM or have contraindications. 6.Using drugs that may affect blood sugar (including steroids, hydroxyprogesterone enanthate, anti-AIDS drugs, etc.). 7.Individuals who are unable to read or understand the content of the informed consent form (e.g., individuals with literacy difficulties or cognitive impairments); 8.Individuals who are unable to independently complete the written informed consent form and do not have a legal guardian or authorised representative to sign on their behalf; 9.Individuals who are unable to care for themselves due to physical or mental reasons and are unable to cooperate with the research process; 10.Other situations where it is impossible to obtain genuine, voluntary, and valid informed consent.

Design outcomes

Primary

MeasureTime frame
Maternal and Neonatal Outcomes;

Secondary

MeasureTime frame
Mean blood sugar;Below range time;Out-of-range time;Coefficient;Standard deviation;Low glycemic index;High glycemic index;Average amplitude of blood glucose fluctuations;Minimum blood glucose value;Maximum blood sugar value;Area under the curve;Postprandial blood sugar spikes;Nocturnal blood glucose variability;Daytime blood glucose variability;

Countries

China

Contacts

Public ContactYufeng Li

Beijing Pinggu Hospital

doctorlyf@126.com+86 10 8999 2258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026